112 related articles for article (PubMed ID: 8334429)
41. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies.
Rabinowe SN; Neuberg D; Bierman PJ; Vose JM; Nemunaitis J; Singer JW; Freedman AS; Mauch P; Demetri G; Onetto N
Blood; 1993 Apr; 81(7):1903-8. PubMed ID: 8461475
[TBL] [Abstract][Full Text] [Related]
43. The use of recombinant human granulocyte-macrophage colony stimulating factor in autologous bone marrow transplantation.
Nemunaitis J; Singer JW
Am J Clin Oncol; 1991; 14 Suppl 1():S15-8. PubMed ID: 2048559
[TBL] [Abstract][Full Text] [Related]
44. Low-dose natural interleukin-2 and recombinant interferon-gamma following autologous bone marrow grafts in pediatric patients with high-risk acute leukemia.
Baumgarten E; Schmid H; Pohl U; Brzoska J; Linderkamp C; Siegert W; Henze G
Leukemia; 1994 May; 8(5):850-5. PubMed ID: 8182941
[TBL] [Abstract][Full Text] [Related]
45. Retrospective analysis of infectious disease in patients who received recombinant human granulocyte-macrophage colony-stimulating factor versus patients not receiving a cytokine who underwent autologous bone marrow transplantation for treatment of lymphoid cancer.
Nemunaitis J; Buckner CD; Dorsey KS; Willis D; Meyer W; Appelbaum F
Am J Clin Oncol; 1998 Aug; 21(4):341-6. PubMed ID: 9708630
[TBL] [Abstract][Full Text] [Related]
46. Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion.
Ageitos AG; Ino K; Ozerol I; Tarantolo S; Heimann DG; Talmadge JE
Bone Marrow Transplant; 1997 Jul; 20(2):117-23. PubMed ID: 9244414
[TBL] [Abstract][Full Text] [Related]
47. [Biologic effects and possible therapeutic use of the granulocyte-macrophage colony-stimulating factor. Modern treatment of leukopenia].
Jovanović-Mićić D; Beleslin DB; Bosnjak S
Srp Arh Celok Lek; 1993; 121(8-12):152-4. PubMed ID: 7725160
[TBL] [Abstract][Full Text] [Related]
48. Natural killer cell numbers and activity in mobilized peripheral blood stem cell grafts: conditions for in vitro expansion.
Silva MR; Parreira A; Ascensão JL
Exp Hematol; 1995 Dec; 23(14):1676-81. PubMed ID: 8542964
[TBL] [Abstract][Full Text] [Related]
49. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
50. Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.
Koukourakis MI; Flordellis CS; Giatromanolaki A; Koukouraki S; Kapsoritakis A; Potamianos S; Retalis G; Sivridis E; Salsaa B; Harris AL; Maragoudakis MI
Clin Cancer Res; 1999 Dec; 5(12):3970-6. PubMed ID: 10632327
[TBL] [Abstract][Full Text] [Related]
51. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.
Takahashi M; Aoki A; Mito M; Nikkuni K; Ohtsuka T; Saitoh H; Moriyama Y; Shibata A
Hematol Pathol; 1993; 7(3):153-8. PubMed ID: 8244908
[TBL] [Abstract][Full Text] [Related]
52. Monocyte-mediated killing of human leukaemia is enhanced by administration of granulocyte-macrophage colony stimulating factor following chemotherapy.
Williams MA; Newland AC; Kelsey SM
Br J Haematol; 1997 Sep; 98(4):960-8. PubMed ID: 9326196
[TBL] [Abstract][Full Text] [Related]
53. L-arginine stimulates host defenses in patients with breast cancer.
Brittenden J; Park KG; Heys SD; Ross C; Ashby J; Ah-See Ak; Eremin O
Surgery; 1994 Feb; 115(2):205-12. PubMed ID: 8310409
[TBL] [Abstract][Full Text] [Related]
54. Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation.
Nagler A; Shur I; Barak V; Fabian I
Leuk Res; 1996 Aug; 20(8):637-43. PubMed ID: 8913316
[TBL] [Abstract][Full Text] [Related]
55. Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors.
Nemunaitis J; Anasetti C; Storb R; Bianco JA; Buckner CD; Onetto N; Martin P; Sanders J; Sullivan K; Mori M
Blood; 1992 May; 79(10):2572-7. PubMed ID: 1586709
[TBL] [Abstract][Full Text] [Related]
56. Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients.
Oosterling SJ; Mels AK; Geijtenbeek TB; van der Bij GJ; Tuk CW; Vuylsteke RJ; van Leeuwen PA; Meijer GA; Meijer S; Beelen RH; van Egmond M
Immunobiology; 2006; 211(6-8):641-9. PubMed ID: 16920503
[TBL] [Abstract][Full Text] [Related]
57. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation.
San Miguel JF; Hernández MD; Gonzalez M; López-Berges MC; Caballero MD; Vazquez L; Orfao A; Nieto MJ; Corral M; del Cañizo MC
Br J Haematol; 1996 Jul; 94(1):140-7. PubMed ID: 8757525
[TBL] [Abstract][Full Text] [Related]
58. Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations.
Demetri GD; Antman KH
Semin Oncol; 1992 Aug; 19(4):362-85. PubMed ID: 1509275
[TBL] [Abstract][Full Text] [Related]
59. Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia.
Faisal M; Cumberland W; Champlin R; Fahey JL
Blood; 1990 Oct; 76(8):1580-5. PubMed ID: 2207331
[TBL] [Abstract][Full Text] [Related]
60. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS.
Bernstein ZP; Brooks SP; Chanan-Khan A; Gollnick SO; Gilbert MJ; Miller KC; Tomasi TB
HIV Clin Trials; 2002; 3(3):219-24. PubMed ID: 12032880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
